Nasdaq FDA - Search News

Amgen wins FDA nod for Lumakras

Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer

The U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of a combination regimen for adults with metastatic colorectal cancer (mCRC) whose tumors harbor an abnormal gene known as KRAS G12C.

Business Insider · 16h

Amgen announces FDA approval of Lumakras in combination with Vectibix

Amgen (AMGN) announced that the U.S. FDA has approved Lumakras in combination with Vectibix for the treatment of adult patients with KRAS

Reuters · 1d

US FDA approves Amgen's colorectal cancer therapy

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.

FDA will allow ZYN Nicotine pouches to stay on market

The Washington Post · 1d

FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes

U.S. News & World Report · 13h

FDA Approves Marketing of Nicotine Pouches

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed to be placed between a person's gum and lip.

Business Insider · 1d

FDA Authorizes All ZYN Nicotine Pouch Products Marketed By Swedish Match In U.S.

The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a

17hon MSN

AstraZeneca's Calquence gains FDA nod for 1L MCL treatment

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market capitalization of $207.67 billion and ...

Investor's Business Daily on MSN11h

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...

Arrowhead says FDA accepts NDA for investigational plozasiran

Pharmaceuticals announced that the U.S. FDA has accepted the New Drug Application for investigational plozasiran for the ...

Nasdaq7d

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab

The FDA filing is supported by data from the phase ... We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that ...

AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday ...

FDA proposes plan to make cigarettes ‘nonaddictive’ by limiting tobacco

The U.S. Food and Drug Administration has issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco ...

Nasdaq7d

FDA Updates EXEL on Previously Scheduled ODAC Meeting for Cabozantinib

The FDA has now notified the company that its sNDA ... We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results